# Detection of Cannabis Impairment With ISBRG's SpotLight-THC

> **NCT05276232** · PHASE1 · UNKNOWN · sponsor: **ISBRG Corp** · enrollment: 75 (estimated)

## Conditions studied

- Cannabis

## Interventions

- **DRUG:** Cannabis(THC) inhaled

## Key facts

- **NCT ID:** NCT05276232
- **Lead sponsor:** ISBRG Corp
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2022-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05276232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05276232, "Detection of Cannabis Impairment With ISBRG's SpotLight-THC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05276232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*